Monday, March 28, 2022

Carlyle Group/PAI to Buy Women's Health Pharma

 

Theramex, the leading global specialty pharmaceuticals company focused on women’s health, will go from private equity underwriter (PEU) ownership under CVC Capital to a consortium comprised of The Carlyle Group and PAI Partners.

The company now serves more than six million women in 57 countries across EMEA, APAC and South America, and employs approximately 480 people (~60% of whom are women).

Three of the four PEUs in the announcement are male.  That's 75%.  How will Theramex fare under a new set of greed and leverage boys?

Carlyle's two representatives include Phillipp Meyer.  His Carlyle bio mentions Edscha, which ended up in bankruptcy.  The U.S. portion defaulted on its pension obligations.  The Pension Benefit Guaranty Corporation received nearly $700,000 to take on a roughly $12 million pension obligation.  

Carlyle normally siphons enough cash from affiliates to cover their initial equity investment before sending them into bankruptcy.  It did so with nursing home giant ManorCare.  I'm sure Mr. Meyer knows very well how much his PEU made on Edscha before passing it's remains to creditors and Uncle Sam.